NovoCare Pharmacy review
This is the drug company selling its own approved product, and the month it quotes is twenty-eight days.
The verdict
NovoCare Pharmacy is Novo Nordisk's own direct-purchase channel for FDA-approved brand semaglutide. The self-pay rate is $349 for a box of four pens, which the page calls a month and which is 28 days, so $378 a calendar month.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide
- Form
- Injection · Oral
- Dose pricing
- Rises with dose
- States
- 50
- From
- $378/mo
- Prescription
- Required
- Compounded
- No
- Availability
- All 50 states
NovoCare Pharmacy dispenses the manufacturer's approved products directly, across fifty states, in pen and tablet form. Nothing here is compounded.
Who writes the prescription, and what do they see?
A prescription is required as it would be at any pharmacy, and the channel is the manufacturer rather than a telehealth seller. That changes who stands behind the product, not who decides you should have it.
Buying from the company that makes the drug removes a whole category of question. There is no compounding pharmacy to identify, no unreviewed preparation, and no ambiguity about what is in the pen. What replaces those questions is a different one about arithmetic.
What happens when the dose goes up?
The cost scales with the dose, and the pen box is the reason: four pens is four weekly doses at whatever strength was prescribed. A higher dose does not stretch a box further, so the cost follows the milligrams in a way the page does not spell out.
What the price includes
Four weekly pens is 28 days, and a year holds 13.04 of those rather than twelve. So $349 is $4,552 a year, or $378 a calendar month. The $25 figure is a commercial-insurance copay subject to a $100 monthly savings cap, which means it describes what insurance pays down rather than what the product costs. The oral tablets are $149 a month for 1.5 mg and 4 mg on a new self-pay offer, with the 4 mg rate rising to $199 when that offer ends.
What it claims, and what it cites
These are FDA-approved brand products dispensed by the manufacturer's own channel. The usual caution about a compounded preparation the FDA has not reviewed does not apply here at all.
Where it holds up, and where it does not
- Strength: FDA-approved product from the maker
- Strength: Coverage across all fifty states
- Strength: Pen and tablet forms both available
- Strength: No compounding pharmacy question at all
- Limitation: A four-pen box is 28 days, not a month
- Limitation: The $25 figure requires commercial insurance
- Limitation: That copay is capped at $100 of savings
- Limitation: The oral offer has a stated end date
What the evidence says about this kind of treatment
The assessment above is about NovoCare Pharmacy. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants the approved product and will count 13 boxes a year rather than 12.
- Wrong for
- A reader comparing $25 against a compounded monthly figure.
How NovoCare Pharmacy compares
| Seller | Who it suits | Go |
|---|---|---|
| PrideRx | Readers who want an approved product and have added the membership to the ladder | See PrideRx → |
| PeterMD | Readers who follow the buttons before believing a figure | See PeterMD → |
 PlexusDx | Readers who want a named product and will read past the entry card | See PlexusDx → |
More GLP-1 telehealth sellers reviews: MEDGmNEUVÉ HealthNextMedsNoBsRxNovaNuBloom
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Is $25 a month what I would pay?
- Only with commercial insurance, and the savings are capped at $100 a month. The self-pay rate is $349 per box of four pens.
- Why is $349 not the monthly cost?
- A box of four weekly pens covers 28 days. A year holds 13.04 of those rather than twelve, so the real figure is about $378 a calendar month.
- Is this compounded semaglutide?
- No. NovoCare Pharmacy is the manufacturer's own channel dispensing FDA-approved brand products, in both pen and tablet form.
- Is NovoCare Pharmacy legit?
- NovoCare Pharmacy is a GLP-1 telehealth sellers service. Its stated availability: All 50 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is NovoCare Pharmacy expensive compared with other GLP-1 telehealth sellers?
- NovoCare Pharmacy publishes a starting figure of $149/mo. Across the 149 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $369 with a median of $179, which puts NovoCare Pharmacy below the median, toward the cheaper end. The other 11 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.